Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00509626 · ClinicalTrials.gov registry record · Phase 1
Physical Activity or Usual Care in Preventing Weight Gain in Women With Stage I or Stage II Breast Cancer Undergoing Chemotherapy
A Phase 1 study, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 380
- Enrollment target
NCT00509626: Completed Phase 1 study, sponsored by Fox Chase Cancer Center.
NCT00509626 is a Phase 1 study that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 380 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (533% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00509626, a Phase 1 study, has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 380 participants
- Enrollment target
Study Summary
RATIONALE: Physical activity may prevent or reduce weight gain in women receiving chemotherapy for early stage breast cancer. PURPOSE: This randomized phase I/II trial is studying physical activity to see how well it works compared with usual care to prevent or reduce weight gain in women with stage I or stage II breast cancer undergoing chemotherapy.
Interventions
- OTHER questionnaire administration
- BEHAVIORAL exercise intervention
- PROCEDURE psychosocial assessment and care
- PROCEDURE management of therapy complications
- PROCEDURE CAM exercise therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 380 participants |
| Start Date | 2007-06 |
| Phase | Phase 1 |
What the finished NCT00509626 record still lists
NCT00509626 is an interventional study that assigns participants to a tested intervention. The registered 380 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (533% higher).
The record links to 0 conditions, and to 5 interventions - of which questionnaire administration is the first listed.
NCT00509626 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00509626 about?
NCT00509626 is a clinical study titled "Physical Activity or Usual Care in Preventing Weight Gain in Women With Stage I or Stage II Breast Cancer Undergoing Chemotherapy". RATIONALE: Physical activity may prevent or reduce weight gain in women receiving chemotherapy for early stage breast cancer. PURPOSE: This randomized phase I/II trial is studying physical activity to see how well it works compared with usual care to prevent or reduce weight gain in women with stag...
What is the current status of trial NCT00509626?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 380 participants. The study started on 2007-06.
What interventions are being tested in trial NCT00509626?
The interventions under investigation include: questionnaire administration (OTHER), exercise intervention (BEHAVIORAL), psychosocial assessment and care (PROCEDURE), management of therapy complications (PROCEDURE), CAM exercise therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00509626?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00509626's enrollment target sits among peer trials
380 81st of 2000 higher than 1,917 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
- NCT04777357 · 380 participants · Phase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- NCT04821154 · 380 participants
Persona Revision Knee System Outcomes
- NCT05102019 · 380 participants · NA
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia